(88 days)
Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank are used for dental restorations using different CAD/CAM or manual milling machines. All blanks are processed through dental laboratories or by dental professionals.
Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank are derived from zirconia powder that has been processed into their final shapes. These blanks are then being further fabricated into all-ceramic restorations such as crowns, bridges, veneers, inlay/onlay. The zirconia powder is composed of ZrO2+ Y2O3+ HfO2+ Al2O3 with its composition conforms to ISO 13356, Implants for surgery – Ceramic materials based on vttriastabilized tetragonal zirconia (Y-TZP). The performance of the dental blanks conforms to ISO 6872, Dentistry - Ceramic materials.
Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank are derived from the same Zirconia powder as the regular Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank with the addition of very small amount of inorganic pigments before the composite material is processed into their final net shapes. These blanks are then being further fabricated into all-ceramic restorations such as crowns, bridges, veneers, inlay/onlay. The purpose of the inorganic pigments is to generate the color on the prosthetic dental devices, after sintering at dental labs, that matches natural color of patient's teeth. The performance of the dental blanks conforms to ISO 6872, Dentistry - Ceramic materials.
This document is a 510(k) Premarket Notification from the FDA for a dental device. It does not describe an AI/ML device, nor does it include a clinical study or a study comparing device performance against acceptance criteria in the way described in your prompt.
The document pertains to the market clearance of "Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank" manufactured by Zhejiang Zahndent Biotechnology Co., Ltd. and compares it to a predicate device (K141724 Upcera Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank).
Here's why the requested information cannot be extracted from this document:
- Not an AI/ML Device: The device described is a physical dental material (zirconia blanks) used for restorations. It does not involve any artificial intelligence, machine learning, or software for diagnosis or analysis.
- No Clinical Study: The document explicitly states: "No clinical study is included in this submission" (Section 9). Therefore, there is no study concerning human readers, AI assistance, or comparative effectiveness.
- Bench Testing for Material Properties: The "studies" mentioned are bench tests performed according to ISO standards, focusing on material properties (flexural strength, chemical solubility, biocompatibility, etc.) to demonstrate substantial equivalence to a predicate device. These are not studies evaluating diagnostic performance or a reader's improvement with AI.
Therefore, I cannot provide the information requested in your prompt as it does not align with the content of the provided document. The document primarily focuses on:
- Device Description: What the dental zirconia blanks are made of and their intended use.
- Comparison to Predicate Device: Highlighting similarities and minor differences in materials and processing.
- Non-Clinical Testing Summary: Reporting the results of biocompatibility and performance tests (e.g., cytotoxicity, irritation, sensitization, toxicity, gene mutation, chromosome aberration, muscle implant) to ensure the device meets established material standards (ISO 6872:2015, ISO 13356, ISO 10993, ISO 7405). All these tests "passed," indicating compliance with the relevant standards for material safety and performance.
If you have a document about an AI/ML medical device with clinical study results, I would be able to extract the requested details.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters 'FDA' in a blue square, followed by the words 'U.S. FOOD & DRUG ADMINISTRATION' in blue text.
June 7, 2024
Zhejiang Zahndent Biotechnology Co., Ltd % Shangfeng Jiang Regulation Control Manager Guangzhou Junyi Information Technology Co., Ltd. Room 304, Building A, No. 62 Nanyun 2nd Road Science Town, Huangpu District Guangzhou City, Guangdong 510663 China
Re: K240672
Trade/Device Name: Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank ( ZD-HT-PLUS, ZD-ST, ZD-SHT, ZD-HT-C, ZD-ST-C, ZD-SHT-C, ZD-UT-C, ZD-ST-ML, ZD-SHT-ML, ZD-UT-ML, ZD-3D-Pro-ML, ZD-4D-Pro-ML) Regulation Number: 21 CFR 872.6660 Regulation Name: Porcelain Powder For Clinical Use Regulatory Class: Class II Product Code: EIH Dated: March 11, 2024 Received: March 11, 2024
Dear Shangfeng Jiang:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Bobak Shirmohammadi -S
For Michael E. Adjodha, M.ChE., RAC, CQIA Assistant Director
{2}------------------------------------------------
DHT1B: Division of Dental and ENT Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
Indications for Use
Form Approved: 0MB No. 0910-0120 Expiration Date: 06/30/2023 See PRA Statement below.
Submission Number (if known)
Device Name
Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank (ZD-HT-PLUS, ZD-ST, ZD-HT-C, ZD-ST-C, ZD-SHT-C, ZD-UT-C, ZD-ST-ML, ZD-SHT-ML, ZD-UT-ML, ZD-3D-Pro-ML, ZD-4D-Pro-ML)
Indications for Use (Describe)
Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank are used for dental restorations using different CAD/CAM or manual milling machines. All blanks are processed through dental laboratories or by dental professionals.
Type of Use (Select one or both, as applicable)
1XPrescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW!
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid 0MB number."
{4}------------------------------------------------
510(k) Summary - K240672
Date of Summary Preparation: February 20, 2024
1. Submitter's Identifications
Submitter's Name: Zhejiang Zahndent Biotechnology Co.,Ltd Address: #203,Building 8,Lecheng Industrial Park, Xingian, HuangYan District, 318020 Taizhou, Zhejiang Province, China Zip Code: 318020 Contact Person: Yaping Huang Contact Title: General Manager Contact E-mail Address: Claire(@zahndent.com Tel: +86-576-84203176
2. Correspondent's Identifications
Correspondent's Name: Guangzhou Junyi Information Technology Co., Ltd. Address: Room 304, Building A, No. 62 Nanyun 2nd Road, Science Town, Huangpu District, Guangzhou City, Guangdong, 510663, China ZIP Code: 510663 Contact Person: Shanfeng Jiang Contact Title: Regulation Control Manager Contact E-mail Address: jiang13620586569@126.com Tel: +86-20-82329549 Fax: +86-20-82329549
3. Name of the Device
Device Classification Name: Powder, Porcelain Regulation Description: Porcelain powder for clinical use Trade Name: Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank Model: ZD-HT-PLUS, ZD-ST, ZD-SHT, ZD-HT-C, ZD-ST-C, ZD-SHT-C, ZD-UT-C, ZD-ST-ML, ZD-SHT-ML, ZD-UT-ML, ZD-3D-Pro-ML, ZD-4D-Pro-ML. Regulation Medical Specialty: Dental Review Panel: Dental Product Code: EIH Regulation Number: 21 CFR 872.6660 Device Classification: Class II
4. The Predicate Devices
Predicate device: K141724 Upcera Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank Liaoning Upcera Company Limited
{5}------------------------------------------------
5. Device Description
Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank are derived from zirconia powder that has been processed into their final shapes. These blanks are then being further fabricated into all-ceramic restorations such as crowns, bridges, veneers, inlay/onlay. The zirconia powder is composed of ZrO2+ Y2O3+ HfO2+ Al2O3 with its composition conforms to ISO 13356, Implants for surgery – Ceramic materials based on vttriastabilized tetragonal zirconia (Y-TZP). The performance of the dental blanks conforms to ISO 6872, Dentistry - Ceramic materials.
Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank are derived from the same Zirconia powder as the regular Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank with the addition of very small amount of inorganic pigments before the composite material is processed into their final net shapes. These blanks are then being further fabricated into all-ceramic restorations such as crowns, bridges, veneers, inlay/onlay. The purpose of the inorganic pigments is to generate the color on the prosthetic dental devices, after sintering at dental labs, that matches natural color of patient's teeth. The performance of the dental blanks conforms to ISO 6872, Dentistry - Ceramic materials.
6. Intended Use of Device
Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank are used for dental restorations using different CAD/CAM or manual milling machines. All blanks are processed through dental laboratories or by dental professionals.
7. Summary of Substantial Equivalence
| Proposed Device | Predicate device | Comparison | |
|---|---|---|---|
| 510k Number | K141724 | ------ | |
| Product Code | EIH | EIH | Same |
| Proprietary Name | Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank | Upcera Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank | ------ |
| Model: | ZD-HT-PLUS,ZD-ST, ZD-SHT,ZD-HT-C, ZD-ST-C,ZD-SHT-C,ZD-UT-C,ZD-ST-ML,ZD-SHT-ML,ZD-UT-ML,ZD-3D-Pro-ML | ------ | ------ |
| ZD-4D-Pro-ML. | |||
| Manufacturer | Zhejiang ZahndentBiotechnologyCo.,Ltd | Liaoning UpceraCompany Limited | ----- |
| Indications forUse | Dental ZirconiaBlank & DentalZirconiaPre-Shaded Blankare used for dentalrestorations usingdifferentCAD/CAM ormanual millingmachines. Allblanks areprocessed throughdental laboratoriesor by dentalprofessionals. | Upcera DentalZirconia Blank &Dental ZirconiaPre-Shaded Blankare used for dentalrestorations usingdifferentCAD/CAM ormanual millingmachines. Allblanks areprocessed thoughdental laboratoriesor by dentalprofessionals. | Same |
| Basic design | Blocks, and rods | Blocks, disc, androd | Same |
| Materials | Regular:Zirconia (ZrO2+Y2O3+ HfO2+$Al2O3≥99.0%$ )Pre-shaded:Zirconia (ZrO2+Y2O3+ HfO2+$Al2O3≥99.0%$ )Inorganic pigments(Fe2O3, Er2O3 andMnO <2.0%) | Regular:Zirconia (ZrO2+Y2O3+ HfO2+$Al2O3≥99.0%$ )Pre-Shaded:Zirconia (ZrO2+Y2O3+ HfO2+$Al2O3≥98.0%$ )Inorganic pigments(Fe2O3, Pr2O3, andEr2O3 <2.0%) | Similar¹ |
| Processing | Sintering attemperature:1450°C | Sintering attemperature:1500°C | Similar² |
| Dimension | Various | Various | Same |
| Single Use | Yes | Yes | Same |
| Color | None, andPre-shaded (forpre-shaded series) | None, andPre-shaded (forpre-shaded series) | Same |
Table 1 Comparison to Predicate Device
{6}------------------------------------------------
{7}------------------------------------------------
The proposed device is essentially identical to the predicate devices in terms of indication for use, design between our device and the predicate devices. The minor differences are that as below:
Note 1: Zirconia (ZrO2+ Y2O3+ HfO2+ Al2O3) of proposed device which is not less than 99.0% is higher than that of the predicate device. The three inorganic pigments of the proposed device contain Fe203, Er2O3 and MnO, while those of the predicate device are Fe2O3, Pr2O3, and Er2O3. These are minor differences and the biocompatibility testing of the overall proposed device passed.
Note 2: Processing (Sintering at temperature) of the proposed device is slightly lower 5°C than that of the predicate device. This is minor difference and the performance testing of the proposed device passed.
8. Summary of Non-Clinical Testing
Bench testing was performed per ISO 6872:2015 and internal procedures to ensure that the Dental Zirconia Blank met its specifications. All tests were verified to meet acceptance criteria. Test results on radioactivity, flexural strength, chemical solubility, linear thermal expansion coefficient, freedom from extraneous materials, uniformity, shrinkage factor, pre-sintered density, sintered density, and fracture toughness of the subject device are very similar to predicate device. Biocompatibility testing was performed to verify the equivalent safety of the materials that are used.
According to ISO 10993-1:2018 and ISO7405:2018, we evaluated and conducted the compatibility test for the proposed device. The following table shows the biocompatibility testing results.
| Item | Proposed device | Result |
|---|---|---|
| Cytotoxicity(ISO 10993-5:2009) | Under the conditions of this study, the test articlewas non cytotoxic for 2 h and 24 h in the filterdiffusion method.Under the conditions of this study, the test articlewas accepted in the agar diffusion method.Under the conditions of this study, the test articlehas no potential toxicity to L-929 cells. | Pass |
| Oral Mucosa Irritation(ISO 10993-23:2021) | The test article has no potential oral mucosairritation in the Syrian hamsters. | Pass |
| Skin SensitizationTest(ISO 10993-10:2021) | The test article showed no evidence of causingdelayed dermal contact sensitization in the guineapig. | Pass |
| Subacute ToxicityTest | The test result showed that the test article did notinduce subacute systemic toxicity in rats under | Pass |
Table 2 Biocompatibility testing
{8}------------------------------------------------
Zhejiang Zahndent Biotechnology Co.,Ltd
| (ISO 10993-11:2017) | this condition . | |
|---|---|---|
| Subacute SystemicToxicity Test(ISO 10993-11:2017) | The test result showed that the test article did notinduce subacute systemic toxicity in rats underthis condition. | Pass |
| Acute SystemicToxicity(ISO 10993-11:2017) | The test article showed no evidence of causingacute system toxicity in the ICR mice. | Pass |
| In Vitro MammalianCell Gene MutationTest(ISO 10993-3:2014) | Under the conditions of this study, the test articleis considered non-mutagenic. | Pass |
| In vitro MammalianChromosomeAberration Test(ISO 10993-3:2014) | Under the conditions of this study, the test articledid not induce structural chromosome aberrationsin cultured CHL cells. | Pass |
| Bacterial ReverseMutation Test(ISO 10993-3:2014) | Under the conditions of this study, the number ofreverting colonies in the test article group is notequal to or greater than 2 times that of thespontaneous control, so the test article have nopotential mutagenesis. | Pass |
| Muscle Implant(ISO 10993-6:2016) | The test result showed that the test article did notinduce local effects after implantation ofbiomaterials in rabbits under this condition. | Pass |
Note: Testing were Performed on Dental Zirconia Blank ST with Pre-Shaded powder C4 (C4 is deep color, see the VITA 16 color shade guide picture) to cover the regular and pre-shaded zirconia blanks.
9. Clinical Test Conclusion
No clinical study is included in this submission.
10. Conclusion:
The conclusions drawn from the nonclinical tests demonstrate that subject device Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank performs as well as or better than the legally marketed predicate device K141724 Upcera Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank. Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank is substantial equivalent to the legally marketed predicate device K141724 Upcera Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank.
§ 872.6660 Porcelain powder for clinical use.
(a)
Identification. Porcelain powder for clinical use is a device consisting of a mixture of kaolin, felspar, quartz, or other substances intended for use in the production of artificial teeth in fixed or removable dentures, of jacket crowns, facings, and veneers. The device is used in prosthetic dentistry by heating the powder mixture to a high temperature in an oven to produce a hard prosthesis with a glass-like finish.(b)
Classification. Class II.